# Management of Hypertension in the Early Postpartum: a Randomized Controlled Trial

Study · id `cardio:ct-nct04835233` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04835233](<https://clinicaltrials.gov/study/NCT04835233>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04835233

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

## Technical summary

Registry record NCT04835233. Randomized; double masking; primary purpose treatment. Start 2021-05-01 (actual); primary completion 2022-12-16 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 180 participants (enrolled count; ClinicalTrials.gov record NCT04835233, source copy `cardio:ctgov-nct04835233-2023-12-28`, retrieved 2026-10-26)
- Started: 2021-05-01 (actual) (ClinicalTrials.gov record NCT04835233, source copy `cardio:ctgov-nct04835233-2023-12-28`, retrieved 2026-10-26)
- Primary completion: 2022-12-16 (actual) (ClinicalTrials.gov record NCT04835233, source copy `cardio:ctgov-nct04835233-2023-12-28`, retrieved 2026-10-26)
- Completion: 2022-12-31 (actual) (ClinicalTrials.gov record NCT04835233, source copy `cardio:ctgov-nct04835233-2023-12-28`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT04835233, source copy `cardio:ctgov-nct04835233-2023-12-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04835233-2023-12-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Management of Hypertension in the Early Postpartum: a Randomized Controlled Trial
- Condition: Pregnancy-Induced Hypertension in Postpartum
- Condition: Postpartum Pre-Eclampsia
- Condition: Hypertension
- Intervention (Drug): Methyldopa 250 MG
- Lead sponsor: Federal University of Paraíba
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: 7e746e46d7cc08abf7aece95f77a4ba7af9b4fc2e8730e9afec75ce9a043c033
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
